Rating History for Nektar Therapeutics (NKTR) by UBS
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/12/2026 | Alice Nettleton | New Coverage | Neutral (N/A) |
53.00 (N/A) |
40.80 (35.78) |
-12.3% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/12/2026 | Alice Nettleton | New Coverage | Neutral (N/A) |
53.00 (N/A) |
40.80 (35.78) |
-12.3% | Details |